PBGENE-DMD has received Investigational New Drug clearance from the U.S. Food and Drug Administration (FDA) enabling initiation of clinical trial site activation. PBGENE-DMD was previously granted FDA ...

Acquisition of Faeth and concurrent $200 million private investment positions the combined company to advance its pipeline ...

Heartflow, Inc. (Heartflow) (Nasdaq: HTFL), the leader in AI technology for coronary artery disease (CAD), today announced that members of management will participate in a fireside chat at the ...

Blue Earth Diagnostics, a Bracco company and recognized leader in the development and commercialization of innovative positron emission tomography (PET) radiopharmaceuticals, today announced that ...

Q32 Bio Inc.  ("Q32 Bio"), a clinical stage biotechnology company focused on developing innovative therapies for alopecia areata (AA) and other autoimmune and inflammatory diseases, today announced ...

Managing bipolar I disorder (BD-I) is a long-term commitment, and factors such as symptoms and side effects influence ...

Tumor Shrinkage of 50% and significant CA-125 biomarker reduction observed at 220 mg dose levelPatient experienced only Grade 1 adverse events ...

Approval decisions from EMA, UK and Switzerland regulators for obicetrapib and obicetrapib/ezetimibe fixed dose combination expected in 2H26 -- -- Phase 3 PREVAIL CVOT blinded event rate tracking in ...

Krystal Biotech, Inc. (NASDAQ:KRYS) Q4 2025 Earnings Call Transcript February 17, 2026 Krystal Biotech, Inc. beats earnings ...

Tactile Systems Technology, Inc. (NASDAQ:TCMD) Q4 2025 Earnings Call Transcript February 18, 2026 Operator: Welcome, ladies and gentlemen, to the Fourth Quarter and Full Year 2025 Earnings Conference ...

Citi's 2026 Virtual Oncology Leadership Summit February 18, 2026 1:00 PM ESTCompany ParticipantsJoshua Bleharski - ...

The New Play Festival commissioned and developed “The House That I Live In; Josh White’s America.” The original musical is ...